Buccal iontophoresis: An opportunity for drug delivery and metabolite monitoring

Drug Discovery Today

Volumn 16, Issue 7-8, 2011, Pages 361-366

  Ciach, Tomasz ^a   Moscicka Studzinska, Aleksandra ^a  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BUCCAL DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; FEEDBACK SYSTEM; IONTOPHORESIS; REVIEW;

ADMINISTRATION, BUCCAL; ANIMALS; COMPUTER SIMULATION; DRUG DELIVERY SYSTEMS; HUMANS; IONTOPHORESIS; PHARMACEUTICAL PREPARATIONS;

EID: 79953680150     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.01.012     Document Type: Review

References (48)

1. S. LeDuc Introduction of medicinal substances into the depth of tissues by electric current Ann. Electrobiol. 3 1900 545 560
2. R.H. Guy Iontophoresis: electrorepulsion and electroosmosis J. Control. Release 64 2000 129 132 (Pubitemid 30035313)
3. Y.N. Kalia Iontophoretic drug delivery Adv. Drug Deliv. Rev. 56 2004 619 658 (Pubitemid 38326937)
4. L.P. Gangarosa Increased penetration of non-electrolytes in to mouse skin during iontophoretic water transport (Iontohydrokinesis) J. Pharmacol. Exp. Ther. 212 1980 377 381 (Pubitemid 10016538)
5. M.J. Pikal, and S. Shah Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurement for hairless mouse skin Pharm. Res. 7 1990 213 221 (Pubitemid 20228558)
6. A. Moscicka-Studzinska Electroosmotic flow as a result of buccal iontophoresis - buccal mucosa properties Eur. J. Pharm. Biopharm. 72 2009 595 599
7. H. Rein Experimental studies on electroosmosis in surviving human skin Z. Biol. 81 1924 125 140
8. R. van der Geest Iontophoretic delivery of apomorphine. I. In vitro optimization and validation Pharm. Res. 14 1997 1798 1803
9. D. Marro Contributions of electromigration and electroosmosis to iontophoretic drug delivery Pharm. Res. 18 2001 1701 1708 (Pubitemid 34020425)
10. S.K. Li In vitro and in vivo comparisons of constant resistance AC iontophoresis and DC iontophoresis J. Control. Release 91 2003 327 343 (Pubitemid 36976764)
11. A.F. Coston, and J.K.J. Li Iontophoresis: modeling, methodology, and evaluation Cardiovasc. Eng. Int. J. 1 2001 127 136
12. E. Neumann, Electroporation and Electrofusion in Cell Biology 1989 Plenum Press
13. M.R. Prausnitz Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery Proc. Natl. Acad. Sci. U. S. A. 90 1993 10504 10508 (Pubitemid 23347070)
14. M.R. Prausnitz A practical assessment of transdermal drug delivery by skin electroporation Adv. Drug Deliv. Rev. 35 1999 61 76 (Pubitemid 29046386)
15. M.R. Prausnitz The effects of electric current applied to skin: a review for transdermal drug delivery Adv. Drug Deliv. Rev. 18 1996 395 425 (Pubitemid 126338020)
16. T. Gürpinar Electromotive drug administration to the urinary bladder: an animal model and preliminary results J. Urol. 156 1996 1496 1501 (Pubitemid 26307646)
17. J.A. Subramony Microprocessor controlled transdermal drug delivery Int. J. Pharm. 317 2006 1 6 (Pubitemid 43866349)
18. C.A. Squier, and B.K. Hall The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier J. Invest. Dermatol. 84 1985 176 179 (Pubitemid 15127885)
19. N.V.S. Madhav Orotransmucosal drug delivery systems: a review J. Control. Release 140 2009 2 11
20. G. Campisi Human buccal mucosa as an innovative site of drug delivery Curr. Pharm. Des. 16 2010 641 652
21. M. Williams, and P. Elias The extracellular matrix of stratum corneum: role of lipids in normal and pathogenical function CRC Crit. Rev. Ther. Drug Carr. Syst. 3 1987 95 122 (Pubitemid 17219200)
22. R.O. Potts Physical characterisation of the stratum corneum: the relationship of mechanical and barrier properties to lipid and protein structure J. Hadgraft, R.H. Guy, Transdermal Drug Delivery: Developmental Issues and Research Initiatives 1989 Marcel Decker Inc. pp. 23-57
23. V. Aguilella Passive transport of small ions through human stratum corneum J. Control. Release 44 1997 11 18 (Pubitemid 27051330)
24. W. Webber Mucosal drug delivery buccal E. Mathiowitz, Encyclopedia of Controlled Drug Delivery 1999 John Wiley & Sons 553 563
25. J.A. Nicolazzo Buccal penetration enhancers - how do they really work? J. Control. Release 105 2005 1 15 (Pubitemid 40805471)
26. S. Rossi Buccal drug delivery: a challenge already won? Drug Discov. Today 2 2005 59 65 (Pubitemid 40946309)
27. N.R. Mathias, and M.A. Hussain Non-invasive systemic drug delivery: developability considerations for alternate routes of administration J. Pharm. Sci. 99 2010 1 20
28. J.A.J. Hoogstraate, and P.W. Wertz Drug delivery via the buccal mucosa Pharm. Sci. Technol. Today 1 1998 309 316 (Pubitemid 28467747)
29. L.I. Giannola Current status in buccal drug delivery Pharm. Technol. Eur. 20 2008 32 39
30. J. Jacobsen TR146 cells grown on filters as a model for human buccal epithelium. I. Morphology, growth, barrier properties, and permeability Int. J. Pharm. 125 1995 165 184
31. J. Jacobsen Buccal iontophoretic delivery of atenolol-HCl employing a new in vitro three-chamber permeation cell J. Control. Release 70 2000 83 95 (Pubitemid 32144795)
32. L.I. Giannola Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design Eur. J. Pharm. Biopharm. 67 2007 425 433 (Pubitemid 47211903)
33. A. Moscicka-Studzinska Electrically enhanced and controlled drug delivery through buccal mucosa Acta Pol. Pharm. Drug Res. 65 2008 767 769
34. A. Moscicka IntelliDrug implant for medicine delivery in Alzheimer's disease treatment Macromol. Symp. 253 2007 134 138 (Pubitemid 47265435)
35. G. Campisi Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs J. Control. Release 145 2010 214 220
36. L.I. Giannola New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies Curr. Pharm. Des. 16 2010 653 659
37. L.I. Giannola Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features Eur. J. Pharm. Biopharm. 65 2007 238 246 (Pubitemid 46038078)
38. O.A. Scholz Drug delivery from the oral cavity: focus on a novel mechatronic delivery device Drug Discov. Today 13 2008 247 253
39. N. Pavšelj A numerical model of skin electropermeabilization based on in vivo experiments Ann. Biomed. Eng. 35 2007 2138 2144 (Pubitemid 350165300)
40. N. Pavselj, and D. Miklavčič A numerical model of permeabilized skin with local transport regions IEEE Trans. Biomed. Eng. 55 2008 1927 1930 (Pubitemid 351871646)
41. N. Pavselj, and D. Miklavčič Numerical models of skin electropermeabilization taking into account conductivity changes and the presence of local transport regions IEEE Trans. Plasma Sci. 36 2008 1650 1658
42. N. Pavšelj, and D. Miklavčič Numerical modeling in electroporation-based biomedical applications Radiol. Oncol. 42 2008 159 168
43. K. Kazmierska, and T. Ciach In silico model for iontophoretic drug delivery through buccal mucosa Proceedings of the 1st Conference on Innovation in Drug Delivery: From Biomaterials to Devices 2007 Publisher p. 349-350
44. S.M. Sims Skin alteration, convective solvent flow effects during iontophoresis. I. Neutral solute transport across human skin Int. J. Pharm. 69 1991 109 121
45. H. Nakamura, and I. Karube Current research activity in biosensors Anal. Bioanal. Chem. 377 2003 446 468 (Pubitemid 40882961)
46. C. Hierold Low power integrated pressure sensor system for medical applications Sens. Actuators A 73 1999 58 67
47. O. Senn Monitoring carbon dioxide tension and arterial oxygen saturation by a single earlobe sensor in patients with critical illness or sleep apnea Chest 128 2005 1291 1296 (Pubitemid 41324409)
48. ® biographer: a continual, non-invasive glucose monitor for patients with diabetes Biosens. Bioelectron 16 2001 621 629 (Pubitemid 33000190)